Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in
NervGen Pharma Corp banner

NervGen Pharma Corp
XTSX:NGEN

Watchlist Manager
NervGen Pharma Corp Logo
NervGen Pharma Corp
XTSX:NGEN
Watchlist
Price: 5.55 CAD -3.31%
Market Cap: CA$446.2m
Write Note Create Alert Ask AI

NervGen Pharma Corp
Investor Relations

NervGen Pharma Corp., a regenerative medicine company, engages in the discovery, development, and commercialization of therapeutics for the treatment of nerve damage, including spinal cord injuries and peripheral nerve injuries. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2019-03-13. The firm is engaged in the discovery, development and commercialization of pharmaceutical products for the treatment of nervous system injury due to trauma or disease as a result of underlying inflammation and/or neurodegeneration. The firm is advancing its lead compound, NVG-291, which is for the treatment of multiple sclerosis (MS), spinal cord injury (SCI) and Alzheimer’s disease. The firm has two wholly owned subsidiaries are NervGen US Inc. and NervGen Australia Pty Ltd.

Show more
Loading
NGEN
S&P TSX Composite Index (Canada)
1Y 3Y 5Y 10Y 15Y 20Y
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Mr. Michael Kelly
CEO, President & Director
No Bio Available
Dr. Harold Martin Punnett D.M.D.
Co-Founder & Independent Director
No Bio Available
Mr. William J. Adams C.A., CPA, CA, CPA
CFO & Corporate Secretary
No Bio Available
Dr. Daniel D. Mikol M.D., Ph.D.
Chief Medical Officer
No Bio Available
Mr. Brian McAlister
Co-Founder & Advisor
No Bio Available
Dr. Charles V. Olson D.Sc.
Senior Vice President of Technical Operations
No Bio Available
Ms. Elizabeth Eberhardt B.Sc.
Senior Vice President of Program Management
No Bio Available

Contacts

Address
BRITISH COLUMBIA
Vancouver
2955 Virtual Way, Suite 480
Contacts
+17787311711.0
www.nervgen.com
sparklesyt

See Also

Summary
NGEN intrinsic value, competitors valuation, and company profile.
DCF Valuation
NGEN stock valuation using Discount Cash Flow valuation method.
Relative Valuation
NGEN stock valuation using valuation multiples.
Wall Street Estimates
NGEN price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
NGEN stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Back to Top
ALPHA SPREAD
Follow us
Join more than 318,600+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.